Durvalumab consolidates treatment breakthroughs: Significantly prolongs the survival of confined small cell lung cancer 26/09/2025
Zenocutuzumab: FDA approves new bispecific antibody for the treatment of NRG1 gene fusion cancer 19/09/2025
Breakthrough in targeted treatment of Tucatinib: New hope for HER2-positive colorectal cancer 07/09/2025
New trends in the treatment of lung cancer, breast cancer, and prostate cancer｜Patient Guide (Excerpted from AIA Internal Sharing｜2025/07/30) 12/08/2025
